ArticleSurgical neurology international2026
Cavernous sinus meningiomas: A retrospective study of natural history, growth dynamics, and treatment response over two decades.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cavernous sinus meningiomas (CSM) pose therapeutic challenges due to their location near critical neurovascular structures. Although microsurgery has been standard, many CSM grow slowly, favoring conservative and radiotherapeutic strategies. This study aimed to describe the natural history, growth patterns, and treatment outcomes of CSM over 20 years. Methods: We retrospectively analyzed 38 patients diagnosed with CSM between 2004 and 2024. Clinical and radiological data were collected, including symptoms, tumor characteristics, growth rates, and treatment. Tumor size and volumetric progression were measured through magnetic resonance imaging. Outcomes were compared by management strategy, and statistical analyses explored associations between demographic, clinical, and radiological factors and the need for intervention. Results: The cohort included 31 women (81.6%) and 7 men (18.4%), mean age 54.5 years, mean follow-up 6.6 years. Diagnosis was incidental in 31.6% and symptom-driven in 68.4%, with ophthalmoplegia most common. Twenty-four patients (63.2%) were managed conservatively, while 14 (36.8%) underwent surgery, radiosurgery, or both. Symptom presence and tumor growth pattern predicted the need for treatment ( Conclusion: CSM generally behave indolently, supporting conservative management in selected patients. Volumetric assessment is more accurate than linear measurement for monitoring growth. Individualized treatment remains essential, and prospective multicenter studies are needed to identify prognostic markers and optimize management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.